Akèy › Gliyoblastòm › Kalifòni › San Francisco
Etid klinik pou Gliyoblastòm nan San Francisco, CA
17 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Ap rekriteFaz 3
- Sutter Health - California Pacific Medical Center, San Francisco
- University of California, San Francisco, San Francisco
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Ap rekriteFaz 1
- University of California San Francisco, San Francisco
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
- UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- University of California, San Francisco
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
Ap rekriteFaz 1
- University of California, San Francisco, San Francisco
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
Ap rekriteFaz 2
- University of California, San Francisco, San Francisco
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
Ap rekriteFaz 2
- University of California, San Francisco, San Francisco
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Ap rekriteFaz 2
- UCSF, San Francisco
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Ap rekriteFaz 1
- University of California, San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- University of California at San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, San Francisco
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Ap rekriteEtid obsèvasyon
- University of California, San Francisco, San Francisco
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Ap rekriteEtid obsèvasyon
- University of California, San Francisco (UCSF), San Francisco
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Ap rekriteEtid obsèvasyon
- University of California, San Francisco, San Francisco
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Ap rekriteEtid obsèvasyon
- University of California, San Francisco, San Francisco
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
Ap rekriteEtid obsèvasyon
- University of California, San Francisco, San Francisco
Etid Gliyoblastòm nan lòt vil
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX26 etid
- Los Angeles, CA24 etid
- Durham, NC20 etid
- Chicago, IL15 etid
- Washington, DC15 etid
- Columbus, OH14 etid
- Miami, FL14 etid
- Rochester, MN13 etid
- Jacksonville, FL13 etid
- Aurora, CO12 etid
Lòt etid nan San Francisco
- Kansè pwostat45 etid
- Kansè nan tete43 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)35 etid
- Ensifizyans kadyak29 etid
- Kansè Metastatik28 etid
- Kansè poumon22 etid
- Melanom22 etid
- Kansè pankreyas20 etid
- Kansè ovè19 etid
- Kansè kolorektal18 etid
- Maladi kadyovaskilè18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.